Teplizumab in Type 1 Diabetes Mellitus: An Updated Review
Touch ENDOCRINOLOGY,
1. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62.
1. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62.
1. In this randomized, double-blind, phase two trial, the use of golimumab led to more C-peptide production, indicative of…
1. In this randomized, double-blind, phase two trial, the use of golimumab led to more C-peptide production, indicative of…
(HealthDay News) -- Taking two 12-week courses of alefacept -- a drug already approved to treat psoriasis -- may help people…